Deep Brain Stimulation (DBS) for Parkinson's Disease International Study
REACH-PD
REACH-PD
Sponsor study identifier
observational
212
2 countries
15
Study Start
July 26, 2017
Actual (reported)Primary Completion
July 30, 2021
Actual (reported)Study Completion
July 30, 2021
Actual (reported)To gather data on DBS Therapy effectiveness in different geographic populations.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 17, 2016
Actual (reported)October 18, 2016
Actual (reported)July 26, 2017
Actual (reported)July 30, 2021
Actual (reported)July 30, 2021
Actual (reported)Change in Parkinson's disease-related quality of life, as measured by the Parkinson's Disease Questionnaire (PDQ-8).
Baseline to 12 months
Change in motor score, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS) III, off medication
Baseline to 12 months
Bilateral Deep Brain Stimulation (DBS) of the Subthalamic Nucleus or Globus Pallidus interna.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Individuals with levodopa responsive Parkinson's disease that are not adequately controlled by medication.
Hospital Universitário Cajuru
Curitiba, Paraná, 80050-350, Brazil
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, 90035-903, Brazil
Santa Casa de Misericordia de Belo Horizonte
Belo Horizonte, 30150-221, Brazil
Hospital Sao Rafael - Monte Tabor
Salvador, 41253-190, Brazil
Hospital de Base de São Jose do Rio Preto
São José do Rio Preto, 15090-000, Brazil
Hospital das Clinicas de Sao Paulo/ IPQ
São Paulo, 01060-970, Brazil
SPDM- Hospital Sao Paulo
São Paulo, 04037-003, Brazil
Zhang Y, Chen L, Sun B, Wang X, Wang J, Wang J, Woods J, Stromberg K, Shang H. Quality of Life and Motor Outcomes in Patients With Parkinson's Disease 12 Months After Deep Brain Stimulation in China. Neuromodulation. 2023 Feb;26(2):443-450. doi: 10.1016/j.neurom.2022.10.047. Epub 2022 Nov 18.
212 participants (actual enrollment reported by the registry).
First Submitted
October 17, 2016
First Posted
October 18, 2016
Study Start
July 26, 2017
Actual (reported)STN-DBS and the Risk of Sialorrhea
Contact the study team to confirm eligibility.
Hospital Santa Marcelina
São Paulo, 08270-070, Brazil
Xuanwu Hospital Capital Medical University
Beijing, 100053, China
Huaxi Hospital
Chengdu, 610041, China
The First Affiliated Hospital of Sun Yat-Sen University
Guangzhou, 510080, China
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, 200025, China
Huashan Hospital
Shanghai, China
The First Hospital of China Medical University
Shenyang, 110001, China
Tangdu Hospital
Xi'an, 710038, China
Primary Completion
July 30, 2021
Actual (reported)Study Completion
July 30, 2021
Actual (reported)Last Updated
October 20, 2022
Record last verified: 2022-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: